MVBF News Alert Mvb Financial Corp (MVBF) 13.3500 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mvb Financial Corp (MVBF) 13.3500 $MVBF

MVB Financial's board approves dividend of USD0.04 per share
M2 - Tue Nov 25, 3:20AM CST
The board of directors of MVB Financial Corp (OTC:MVBF) (OTCQB:MVBF), a bank holding company, authorised a cash dividend of USD0.04 per share, the company reported on Monday.

MVB Financial declares $0.04 dividend
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 3:21PM CST


MVB Financial Corp. Board of Directors Declares Dividend of $0.04 per Share for Shareholders of Record, December 16, 2014
PR Newswire - Mon Nov 24, 3:15PM CST
The Board of Directors of MVB Financial Corp., (OTC Markets Group OTCQB: MVBF) has declared a cash dividend of $0.04 per share to shareholders of record at the close of business on December 16, 2014, payable December 31, 2014.

MVB Financial Third Quarter Results Show Strong Deposits and Loan Growth
PR Newswire - Fri Nov 14, 3:15PM CST
MVB Financial Corp., (OTC Markets Group OTCQB: MVBF) today announced quarterly results for the period ending September 30, 2014. MVB Financial and its subsidiaries - MVB Bank, MVB Mortgage, and MVB Insurance (collectively "MVB" - reported total net income of $537,000.

MVB Financial and CFG Community Bank agree to terminate asset acquisition
PR Newswire - Fri Oct 31, 3:43PM CDT
MVB Financial Corp., (OTC Markets Group OTCQB: MVBF), and Maryland-based CFG Community Bank (CFG) today jointly announced that they have terminated MVB's proposed approximately $30 million asset acquisition by mutual agreement. Both parties have released each other from all obligations with no termination fee required by either entity.

MVB Financial Corp. Announces Results for Second Quarter 2014
PR Newswire - Mon Aug 11, 10:48AM CDT
MVB Financial Corp., (OTC Markets Group OTCQB: MVBF) today announced quarterly results for the period ending June 30, 2014. MVB Financial and its subsidiaries - MVB Bank, MVB Mortgage, and MVB Insurance (collectively "MVB" - reported total net income of $969,000. Results for the second quarter of 2014 include the impact of interest expense on funds escrowed during the capital raise for subordinated debt and preferred stock, which was announced at the end of June. The escrow interest expense was $552,000 on a pre-tax basis. Income before taxes was lower by 15.2 percent, or $212,000, compared to the first quarter of 2014. However, by excluding the impact of the escrow interest expense, income before taxes would have reflected an increase of 24 percent, or $340,000, also compared to first quarter of this year.

MVB Financial Raises $52.8 Million To Support Future Growth
PR Newswire - Mon Jun 30, 3:01PM CDT
MVB Financial Corp., (OTCQB: MVBF) (the "Company" , the parent company of MVB Bank, Inc. (the "Bank" , MVB Mortgage and MVB Insurance, LLC, announced today that it has completed a series of private placements resulting in gross proceeds of approximately $52.8 million.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

KPN Achieves Impressive Growth; Forecast for 2025 Enhanced

Updated Category News Views 271

KPN Achieves Remarkable Growth in Q2 2025 KPN has recently demonstrated a strong performance in the second quarter of 2025, showcasing impressive growth across various segments. The company reported a year-on-year growth of 3.7% in service revenues, a testament to its robust business strategy and market position. Consumer Service Revenue Gains The consumer segment has...

Continue Reading
Socket Mobile's Financial Trends Show Promise for Future Growth

Updated Category News Views 66

Socket Mobile Reports Q3 Financial Results Socket Mobile, Inc. (NASDAQ: SCKT), a prominent name in the field of data capture and delivery solutions, recently disclosed its financial results for the third quarter of 2024, presenting notable shifts in revenue and product adoption. The company emphasizes its commitment to enhancing productivity through innovative...

Continue Reading
Sapiens Recognized for Outstanding Software Solutions Excellence

Updated Category News Views 220

Sapiens UnderwritingPro Achieves Recognition for Excellence Sapiens International Corporation has once again made waves in the insurance industry with its advanced UnderwritingPro solution. Renowned for driving efficiency and automation, the software provides comprehensive functionality that benefits insurers across various sectors. Honored with the XCelent Award...

Continue Reading
Opportunity for LAZR Investors: Join the Class Action Today

Updated Category News Views 175

Investing in Luminar Technologies: What You Need to Know For those invested in Luminar Technologies, Inc. (NASDAQ: LAZR), important news is unfolding regarding a recent class-action lawsuit that has potential implications for shareholders. The Rosen Law Firm, a reputable entity in securities law, has issued a reminder for investors who purchased Luminar securities during...

Continue Reading
Celebrating HVAC Techs: Behind-the-Scenes Heroes

Updated Category News Views 8

Recognizing the Unsung Heroes of Home Comfort Let's face it, HVAC techs don't always get the recognition they deserve. On National HVAC Technician Day, June 22, Bacon Plumbing Heating Air Electric took a moment to shine a light on those skilled folks keeping homes comfy year-round across the Dallas-Fort Worth Metroplex. You know, the folks who swoop in just in time during...

Continue Reading